Aquinox Pharmaceuticals (AQXP) Short Interest Ratio & Short Volume

Short interest is the volume of Aquinox Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of August 15th, investors have sold 30,000 shares of AQXP short. 0.13% of Aquinox Pharmaceuticals' shares are currently sold short. Learn More on Aquinox Pharmaceuticals' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.13% of Aquinox Pharmaceuticals' floating shares are currently sold short.

Aquinox Pharmaceuticals saw a decrease in short interest during the month of August. As of August 15th, there was short interest totaling 30,000 shares, a decrease of 43.6% from the previous total of 53,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Aquinox Pharmaceuticals currently has issued a total of 23,540,000 shares. Some of Aquinox Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aquinox Pharmaceuticals currently has a public float of 23,390,000 shares.

0.13% of Aquinox Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Aquinox Pharmaceuticals: Disc Medicine, Inc. (14.71%), Centessa Pharmaceuticals plc (6.20%), Arcutis Biotherapeutics, Inc. (15.84%), Edgewise Therapeutics, Inc. (18.56%), Schrödinger, Inc. (16.05%), Biohaven Ltd. (12.74%), 89bio, Inc. (13.50%), ARS Pharmaceuticals, Inc. (31.29%), Evotec SE (0.23%), ANI Pharmaceuticals, Inc. (10.35%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Netflix, Inc. ($6.50 billion), Fidelity National Information Services, Inc. ($5.01 billion), Charter Communications, Inc. ($4.02 billion), Microchip Technology Incorporated ($3.01 billion), Occidental Petroleum Corporation ($2.16 billion), Omnicom Group Inc. ($2.03 billion), Block, Inc. ($2.00 billion), Global Payments Inc. ($1.76 billion), Match Group Inc. ($1.66 billion), and Hormel Foods Corporation ($1.66 billion). View all of the most shorted stocks.

Short selling AQXP is an investing strategy that aims to generate trading profit from Aquinox Pharmaceuticals as its price is falling. AQXP shares are trading down $0.54 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Aquinox Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AQXP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AQXP, twice per month. The most recent reporting period available is August, 15 2019.